Living up to its moniker of a defensive bet, the Rs 2.8 trn Indian pharmaceutical sector is set to emerge more or less unscathed from the Covid-19 pandemic this fiscal, CRISIL said on Thursday.
from Companies https://ift.tt/364mTvS
via IFTTT
from Companies https://ift.tt/364mTvS
via IFTTT
Comments
Post a Comment